Pharmabiz1h
Anixa Biosciences begins patient dosing in third cohort in ongoing phase 1 trial of novel CAR-T therapy for recurrent ovarian cancer
Anixa Biosciences begins patient dosing in third cohort in ongoing phase 1 trial of novel CAR-T therapy for recurrent ovarian cancer: San Jose, California Wednesday, November 20, ...
Pharmabiz2h
NIH-developed AI algorithm matches potential volunteers to clinical trials
NIH-developed AI algorithm matches potential volunteers to clinical trials: Bethesda, Maryland Wednesday, November 20, 2024, 17:00 Hrs [IST] Researchers from the National Institut ...
Pharmabiz3h
TAHO Pharma begins patient dosing in US phase III trial of antithrombotic oral dissolving film, TAH3311
TAHO Pharma begins patient dosing in US phase III trial of antithrombotic oral dissolving film, TAH3311: Taipei Wednesday, November 20, 2024, 16:00 Hrs [IST] TAHO Pharmaceuticals ...
Pharmabiz4h
Cytokinetics, Bayer enter collaboration and licensing pact to develop & commercialize aficamten in Japan
Cytokinetics, Bayer enter collaboration and licensing pact to develop & commercialize aficamten in Japan: South San Francisco, California Wednesday, November 20, 2024, 15:00 Hrs [ ...
Pharmabiz4h
Granules India appoints Ovais Sarmad as advisor to guide on Sustainability and Climate Strategy
Granules India appoints Ovais Sarmad as advisor to guide on Sustainability and Climate Strategy: Our Bureau, Bengaluru Wednesday, November 20, 2024, 14:40 Hrs [IST] Granules India ...
Pharmabiz4h
Sova Health launches Sova X, a personalized gut health solution based on each individual's microbiome
Sova Health launches Sova X, a personalized gut health solution based on each individual's microbiome: Our Bureau, Bengaluru Wednesday, November 20, 2024, 14:30 Hrs [IST] Gut-heal ...
Pharmabiz4h
Sightsavers India with AbbVie India hosted the 4th state-level consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’
Sightsavers India and AbbVie India, in their ongoing collaborative campaign, hosted the fourth state-level consultation on the ‘Prevention of Visual Impairment Caused by Glaucoma.’ Glaucoma, a leading ...
Pharmabiz4h
Telangana govt holds “AI in Healthcare Summit Road to BioAsia 2025
Telangana govt holds “AI in Healthcare Summit Road to BioAsia 2025: Our Bureau, Bengaluru Wednesday, November 20, 2024, 14:10 Hrs [IST] The Government of Telangana organized “ ...
Pharmabiz5h
UK MHRA grants marketing authorization to sparsentan to treat adult patients with primary immunoglobulin A nephropathy
UK MHRA grants marketing authorization to sparsentan to treat adult patients with primary immunoglobulin A nephropathy: United Kingdom Wednesday, November 20, 2024, 14:00 Hrs [IST ...
Pharmabiz5h
Indegene expands global delivery network, announces a new centre in Hyderabad
Indegene expands global delivery network, announces a new centre in Hyderabad: Our Bureau, Bengaluru Wednesday, November 20, 2024, 13:30 Hrs [IST] Indegene, a digital-first life s ...
Pharmabiz6h
Late-breaking data reinforce long-term benefits of Abbott's Amplatzer Amulet device for people with atrial fibrillation at risk of stroke
Abbott Park, Illinois Wednesday, November 20, 2024, 13:00 Hrs [IST] ...
Pharmabiz6h
Tata Elxsi, DENSO and AAtek set-up ‘Robotics and Automation Innovation Lab’ in Frankfurt
Tata Elxsi, DENSO and AAtek set-up ‘Robotics and Automation Innovation Lab’ in Frankfurt: Our Bureau, Bengaluru Wednesday, November 20, 2024, 12:50 Hrs [IST] Tata Elxsi, a glo ...